Baird JH, Gotlib J. Clinical validation of KIT inhibition in Advanced systemic mastocytosis. Curr Hematol Malig Rep. 2018;13:407–16. https://doi.org/10.1007/s11899-018-0469-3.

Article  PubMed  Google Scholar 

Metcalfe DD. Mast cells and mastocytosis. Blood. 2008;112:946–56. https://doi.org/10.1182/blood-2007-11-078097.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pardanani A. Systemic mastocytosis in adults: 2021 update on diagnosis, risk stratification and management. Am J Hematol. 2021;96:508–25. https://doi.org/10.1002/ajh.26118.

Article  PubMed  Google Scholar 

Kibsgaard L, Deleuran M, Flohr C, Langan S, Braae Olesen A, Vestergaard C. How benign is cutaneous mastocytosis? A Danish registry-based matched cohort study. Int J Womens Dermatol. 2020;6:294–300. https://doi.org/10.1016/j.ijwd.2020.05.013.

Article  PubMed  PubMed Central  Google Scholar 

Ungerstedt J, Ljung C, Klimkowska M, Gülen T. Clinical outcomes of adults with systemic mastocytosis: a 15-Year multidisciplinary experience. Cancers (Basel). 2022;14. https://doi.org/10.3390/cancers14163942.

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405. https://doi.org/10.1182/blood-2016-03-643544.

Article  CAS  PubMed  Google Scholar 

Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O, et al. Updated diagnostic criteria and classification of mast cell disorders: a Consensus proposal. Hemasphere. 2021;5:1–12. https://doi.org/10.1097/hs9.0000000000000646.

Article  CAS  Google Scholar 

Pardanani A. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management. Am J Hematol. 2023;98:1097–116. https://doi.org/10.1002/ajh.26962.

Article  CAS  PubMed  Google Scholar 

Khoury JD, Solary É, Abla O, Akkari YM, Alaggio RD, Apperley J, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and Histiocytic/Dendritic neoplasms. Leukemia. 2022;36:1703–19. https://doi.org/10.1038/s41375-022.

Article  PubMed  PubMed Central  Google Scholar 

Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, et al. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis. Mod Pathol. 2014;27:19–29. https://doi.org/10.1038/modpathol.2013.117.

Article  CAS  PubMed  Google Scholar 

Fuchs D, Kilbertus A, Kofler K, von Bubnoff N, Shoumariyeh K, Zanotti R, et al. Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin. J Allergy Clin Immunology: Pract. 2021;9:1705–e17124. https://doi.org/10.1016/j.jaip.2020.12.022.

Article  CAS  Google Scholar 

Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129:1420–7. https://doi.org/10.1182/blood.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. International Consensus classification of myeloid neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, et al. Advances in the classification and treatment of mastocytosis: current status and outlook toward the future. Cancer Res. 2017;77:1261–70. https://doi.org/10.1158/0008-5472.CAN-16-2234.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim K-H, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113:5727–36. https://doi.org/10.1182/blood-2009-02.

Article  CAS  PubMed  Google Scholar 

Cohen SS, Skovbo S, Vestergaard H, Kristensen T, Møller M, Bindslev-Jensen C, et al. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol. 2014;166:521–8. https://doi.org/10.1111/bjh.12916.

Article  PubMed  Google Scholar 

Van Doormal JJ, Arends S, Brunekreeft KL, van der Wa BV, Sietsma J, van Voorst Vader PC, et al. Prevalence of indolent systemic mastocytosis in a Dutch region. J Allergy Clin Immunol. 2013;131:1429–31. https://doi.org/10.1016/j.jaci.2012.10.014.

Article  Google Scholar 

Zanotti R, Bonifacio M, Isolan C, Tanasi I, Crosera L, Olivieri F, et al. A multidisciplinary diagnostic approach reveals a higher prevalence of indolent systemic mastocytosis: 15-years’ experience of the gism network. Cancers (Basel). 2021;13. https://doi.org/10.3390/cancers13246380.

Bergström A, Hägglund H, Berglund A, Nilsson G, Lambe M. Epidemiology of mastocytosis: a population-based study (Sweden). Acta Oncol (Madr). 2024;63:44–50. https://doi.org/10.2340/1651-226X.2024.31406.

Article  Google Scholar 

Valent P, Hartmann K, Bonadonna P, Sperr WR, Niedoszytko M, Hermine O, et al. European competence network on mastocytosis (ECNM): 20-Year Jubilee, Updates, and future perspectives. J Allergy Clin Immunology: Pract. 2023;11:1706–17. https://doi.org/10.1016/j.jaip.2023.02.021.

Article  Google Scholar 

Gotlib J, George TI, Carter MC, Austen KF, Bochner B, Dwyer DF et al. Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference. Journal of Allergy and Clinical Immunology, vol. 147, Mosby Inc.; 2021, pp. 2043–52. https://doi.org/10.1016/j.jaci.2021.03.008

Hoermann G, Sotlar K, Jawhar M, Kristensen T, Bachelot G, Nedoszytko B, et al. Standards of genetic testing in the diagnosis and prognostication of systemic mastocytosis in 2022: recommendations of the EU-US Cooperative Group. J Allergy Clin Immunology: Pract. 2022;10:1953–63. https://doi.org/10.1016/j.jaip.2022.03.001.

Article  CAS  Google Scholar 

Arock M, Sotlar K, Akin C, Broesby-Olsen S, Hoermann G, Escribano L, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the European competence network on mastocytosis. Leukemia. 2015;29:1223–32. https://doi.org/10.1038/leu.2015.24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kristensen T, Vestergaard H, Bindslev-Jensen C, Møller MB, Broesby-Olsen S, Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis. Am J Hematol. 2014;89:493–8. https://doi.org/10.1002/ajh.23672

Article  CAS  PubMed  Google Scholar 

Kristensen T, Vestergaard H, Bindslev-Jensen C, Møller MB, Broesby-Olsen S. Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosis. Allergy: Eur J Allergy Clin Immunol. 2020;75:1489–91. https://doi.org/10.1111/all.14165.

Article  CAS  Google Scholar 

Gotlib J, Kluin-Nelemans HC, George TI, Akin C, Sotlar K, Hermine O, et al. Efficacy and safety of midostaurin in Advanced systemic mastocytosis. N Engl J Med. 2016;374:2530–41. https://doi.org/10.1056/nejmoa1513098.

Article  CAS  PubMed  Google Scholar 

Muñoz-González JI, Álvarez-Twose I, Jara-Acevedo M, Zanotti R, Perkins C, Jawhar M, et al. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study. Lancet Haematol. 2021;8:e194–204. https://doi.org/10.1016/S2352-3026(20)30400-2.

Article  PubMed  Google Scholar 

Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–9. https://doi.org/10.1007/s10654-014-9930-3.

Article  PubMed  Google Scholar 

Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22–5. https://doi.org/10.1177/1403494810387965.

Article  PubMed  Google Scholar 

Pedersen CB, Gøtzsche H, Møller JØ, Mortensen PB, Med Bull D. The Danish Civil Registration System a cohort of eight million persons. Dan Med Bull. 2006;53:441–9.

PubMed  Google Scholar 

Arendt JFH, Hansen AT, Ladefoged SA, Sørensen HT, Pedersen L, Adelborg K. Existing data sources in clinical epidemiology: Laboratory information system databases in Denmark. Clin Epidemiol. 2020;12:469–75. https://doi.org/10.2147/CLEP.S245060.

Article  PubMed  PubMed Central  Google Scholar 

Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90. https://doi.org/10.2147/CLEP.S91125.

Article